0001104659-21-005833.txt : 20210120
0001104659-21-005833.hdr.sgml : 20210120
20210120161617
ACCESSION NUMBER: 0001104659-21-005833
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20210119
FILED AS OF DATE: 20210120
DATE AS OF CHANGE: 20210120
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: GILL DAVID N
CENTRAL INDEX KEY: 0001106519
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-38650
FILM NUMBER: 21538947
MAIL ADDRESS:
STREET 1: C/O NXSTAGE MEDICAL INC. (NXTM)
STREET 2: 439 SOUTH UNION STREET, 5TH FLOOR
CITY: LAWRENCE
STATE: MA
ZIP: 01843
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Y-mAbs Therapeutics, Inc.
CENTRAL INDEX KEY: 0001722964
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 474619612
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 750 THIRD AVENUE
STREET 2: 9TH FLOOR
CITY: NEW YORK
STATE: NY
ZIP: 10017
BUSINESS PHONE: 212-847-9841
MAIL ADDRESS:
STREET 1: 750 THIRD AVENUE
STREET 2: 9TH FLOOR
CITY: NEW YORK
STATE: NY
ZIP: 10017
4
1
tm211939-2_4.xml
OWNERSHIP DOCUMENT
X0306
4
2021-01-19
0
0001722964
Y-mAbs Therapeutics, Inc.
YMAB
0001106519
GILL DAVID N
C/O Y-MABS THERAPEUTICS, INC.
230 PARK AVENUE SUITE 3350
NEW YORK
NY
10169
1
0
0
0
Common Stock
2021-01-19
4
M
0
2000
11.16
A
2000
D
Common Stock
2021-01-19
4
S
0
2000
46.5226
D
0
D
Non-Employee Stock Option (right to buy)
11.16
2021-01-19
4
M
0
2000
0
D
2028-04-24
Common stock
2000
24000
D
The option exercise and sale transaction reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan previously adopted by the Reporting Person.
This transaction was executed in multiple trades at prices ranging from $45.9500 to $47.6800. The price reported reflects the weighted average sale price. The Reporting Person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the transaction was effected.
Stock option granted to the Reporting Person as a non-employee director pursuant to the 2015 Equity Incentive Plan of Y-mAbs Therapeutics, Inc.
The stock option was (a) granted on April 24, 2018 pursuant to the 2015 Equity Incentive Plan of Y-mAbs Therapeutics, Inc., and (b) represents the right to purchase a total of 32,000 shares of common stock; and (c) vests and becomes exercisable in equal monthly installments until the third anniversary of the date of grant subject to continued service through such dates and unless vesting is accelerated pursuant to the terms of the grant.
/s/ David N Gill
2021-01-20